42
How do you do that?

Digipharm workshop2011

Embed Size (px)

DESCRIPTION

Pre-conference workshop at exl digipharma held March 28th, 2011 @Boehringer headquarters by Silja Chouquet and Sabine Kostevc

Citation preview

Page 1: Digipharm workshop2011

How do you do that?

Page 2: Digipharm workshop2011

Source: What the f**k is social media, Espresso, brandinfiltration.com

A social media definition

Page 3: Digipharm workshop2011
Page 4: Digipharm workshop2011

A societal phenomena?

“Society must be organized in such a way that man's social, loving nature is not separated from his social existence, but becomes one with it.”

Erich Fromm

Page 5: Digipharm workshop2011

Online tribes...

Page 6: Digipharm workshop2011

Roche Group Communications

Online Health Audience Growing (USA)

2002 2003 2004 2005 2006 2007 2008 2009

26.041.1 45.7

54.5

70.881.4

93.5102.3

63.3

82.889.6

99.0

116.2

131.8145.7

157.5

eHealth ConsumersePharma Consumers

Adults Online Past 12 Months179.6 million

Online for Health

157.5 million

“eHealth”

Online for Rx Info 102.3

million

“ePharma”

Online and eHealth Market Trending Online Health Info Seeking

*

**

* eHealth Consumers = Consumers who have conducted health information seeking activities online in the past 12 months for themselves or others.

** ePharma Consumers = Consumers who have researched prescription drug information online in the past 12 months for themselves or others.Source: Cybercitizen Health®

v2.0-9.0

In Millions

Page 7: Digipharm workshop2011

Roche Group Communications

HCP Use of Online/Social Media Has Grown

1 Manhattan Research, Taking the PulseTM v9.0, 2009. 2 Manhattan Research, Taking the PulseTM v8.0, 2008. 3 Manhattan Research ePharma Physician® v9.0(All statistics drawn from press releases, published white papers and other publicly available sources). Accessed at

www.manhattanresearch.com

Average Physician Spends 8 Hours Per Week Online for Professional Purposes (vs.2.5 Hours in 2002) 1

87%

60%

56%

64%

Already interact with drug and device companies online(up 23% since 2004) 1

Are already using or are interested in physician onlinecommunities 2

Are interested in using social media to have productdiscussions with healthcare companies 3

Currently have smart phonesThis is expected to increase to 81% by 20121

Page 8: Digipharm workshop2011

Roche Group Communications

Top Pharma companies are getting active

CompanySocial Media

Policy Complete or in Development

Social Media “Listening”

Corporate Social Media Activities

Brand / Product Social Media

Activities

Disease Awareness Social Media Activities

JnJ

Pfizer

Roche

GlaxoSmithKline

Novar7s

Sanofi-­‐Aven7s

AstraZeneca

Abbo=  

Merck

Bayer

Eli  Lilly

Bristol  Myers  Squibb

3

Page 9: Digipharm workshop2011

Roche Group Communications

Empowered Patients are Helping Each Other…

…Doctors Too

4

www.nhs.uk

Page 10: Digipharm workshop2011

No “one size fits all” model Approach will be different based on goal

• Brand building• Reputation management• Crisis communication• Customer support • Product development• Generating orders• Education• …

Roche Group Communications

Page 11: Digipharm workshop2011

The Value of Listening first

Monitoring can inform us:

• What the top issues are that matter to our customers

• Where our customers live online• How you can add value for our

customers• When you should engage the

community• Why customers are passionate on

certain topics• Who is driving share of voice

Roche Group Communications

Page 12: Digipharm workshop2011

Corporate    comms

Brand  teams Clinical  development

Market  research

Listening objectives - different parts of the organization have different objectives for listening

Func7on

12

Page 13: Digipharm workshop2011

Where to start?

Who’s  Online?

What  should  I  listen  too?

How  do  they  speak?

What  are  they    actually  saying?

What  search  terms  should  I  

use?

Page 14: Digipharm workshop2011

Let the information come to you

Social  MediaListening  Techniques

Data

Well-­‐defined  sources  

EffecEve  search  terms

Unbiased,relevant  insights

Page 15: Digipharm workshop2011

Where to listen to what?

Page 16: Digipharm workshop2011

3

messages

Page 17: Digipharm workshop2011

Boolean  Basics

• cat  OR  dog

• cat  AND  dog  

• cat  NOT  dog

     cat      dog

cat dog

cat dog

Page 18: Digipharm workshop2011

Unique vs. Common

VS.          

Page 19: Digipharm workshop2011

And how should I sort the sources?

World  Wide  Web

Social  Media

Project/Disease  Specific

Page 20: Digipharm workshop2011

Accuracy vs Amount

Page 21: Digipharm workshop2011

Sentiment

21

Page 22: Digipharm workshop2011

How  do  we  balance  it  out?

Page 23: Digipharm workshop2011

Different social media listening outputs

• Understand customer needs and ecosystem• Identify main themes of customer discussions• Evaluate attitudes and sentiments• Etc.

Social media audit

•Identify voices driving critical conversations

•Profile key online influencers online and offline

•Understand what motivates them and how you can engage

Influence mapping

•Reputation tracking•Safety issue monitoring•Brand tracking•Measure impact of promotional efforts

Interactive Dashboard

1

2

3

Page 24: Digipharm workshop2011

Thoughts of AE reporting

Majority of AEs identified on social media not reportable

1.an identifiable patient2.an identifiable reporter3.a specific drug or biologic involved in the event4.an adverse event or fatal outcome

Only 1 in 500 posts have all this info.

Page 25: Digipharm workshop2011

Can pharma use twitter to engage?

Page 26: Digipharm workshop2011

Twitter basics

29

Connect

Followers

Following

Post

Retweet RT

Direct message

D

Hashtag

#

Reply@

Participate

Page 27: Digipharm workshop2011

30

Direct message

YOU HER

= email

Page 28: Digipharm workshop2011

30

@ reply

YOU HER

= email, cc everyone

Page 29: Digipharm workshop2011

30

RT

YOUHER

= forward mail, cc everyone

Page 30: Digipharm workshop2011

Roche’s Twitter use casesMix of information and contact channel

Monitoring of relevant topics

Early warning on issues

New back channel for questions

Gather Feedback and service ideas

Additional channel for info distribution

Connect with stakeholders

Conference/event coverage

Human voice

In-bound out-bound

Roche Group Communications

Page 31: Digipharm workshop2011

Roche Twitter case studyExample: outbreak of swineflu in spring 2009

Monitoring showed peak in mentions of Roche and Tamiflu, influenza

We tweeted links to • backgrounders on pandemic planning

• Educational info about influenza

• news by WHO, CDC …

• Answered media enquiries for b-roll, photos, details

• Directed to local media contacts

• Corrected mis-information…

Page 32: Digipharm workshop2011

Roche Twitter case studyExample: Diabetes Blogger complaining

• Provided UK helpline details

-> blogger not interested in calling, wants answer on his channel

• informed UK communications + Accu-Chek team to follow up

• gave (DM) updates to blogger that matter was looked into

Page 33: Digipharm workshop2011

IR & Media News(can be automated)

Build a profile and engage followersthrough:

• Responses• Re-Tweets• Questions• Science topics• Pictures•„non-business“ tweets

Page 34: Digipharm workshop2011

2008 2009

@Boehringer@Novar7s

@JNJComm@Roche_com

@AstraZenecaUS @Amgen@genentechnews@GSKUS

@Pfizernews@AstraZeneca

2010

Over past 18 month big pharma set up a presence on twitter

Whydot twitter analysis

34

Start  of  twiYer  ac7vi7es

Page 35: Digipharm workshop2011

!"

#$#%"

$!&'"%('"

$)%&"$%$*"

$$%*" $$)$"*+$"

!" !"

()+$" ('%&"

#&*+" #*%)"((!+"

#*'!" #+)#" #(%$"$')+"

$!!%"##+"

)+$*"

*+!!"

&')!"&(*%"

+)!%" +*&$"

()'!"(%'$"

((*)" (#$+"

$$)$"

!"

$!!!"

#!!!"

(!!!"

+!!!"

&!!!"

%!!!"

*!!!"

'!!!"

)!!!"

$!!!!"

,-./0123045"

,67891:5"

,;7<=0"

,>?@A?"

,B70=1C3D01"

,E6EF7GG"

,D0303H0<=3045"

,I5H19J030<9A?"

,IGD03"

,I5H19J030<9"

,K01H0L-=91G9"

!"#$%&'()'*(++(,%&-'(.'/,01%&'MENO"!)P"Q0<"!)P"R<H"$!S"

Source:  www.twiYer.com,  July  13th,Dec  31st  2009,  October  18th;  whdotpharma  analysis

Despite late entry, Pfizer most followers

35

#  of  Followers

Avrg  followers:  4835

Page 36: Digipharm workshop2011

!"##$"

"%"

!"%$#"

"!&'""%"

"!()""%" "#%" "*&" "$" "%"

)+)(&"

!+',!" !+',#"

,%'"

!,'"'',"

!%!" !%%" *(" !!" %"

)+,*$"

)+!!!"

!+&#%"

$,&"(%#"

'#&"!##" !)(" *$" $" %"

%"

#%%"

!%%%"

!#%%"

)%%%"

)#%%"

'%%%"

-./01234502"

-67802940:;"

-<=<>/??"

-@/A10"

-B02C0D61E2?E"

-F;C2EG040AEHI"

-F;C2EG040AE"

-JIKHI"

-50404C0A140:;"

-=/LE2M;"

-F?504"

!"#$%&'()'*(++(,-./'(.'0,-1%&''N<OP"%$+"Q0A"%$+"RAC"!%S"

Divide on “following” policy

36

#  of  Following

Source:  www.twiYer.com,  July  13th,Dec  31st  2009,  October  18th;  whdotpharma  analysis

Avrg  following:  793

Page 37: Digipharm workshop2011

!""#

"$$#

%&"#

'%# ('#%)# *# *# %*# &# *#

&!+#$+(#

!'*#!*!#

"!!#%*(#

)'# ('# ("# '+#!(#

"*'$# "*)'#

$$!#$*)#

+*+#!+'#

%$!# %!*#"'+# ")%# "$&#

*#

%$*#

$**#

($*#

"***#

"%$*#

,-.-/011#

,20345#

,6054789:57#

,;<=7>?5953>@A#

,.0B>7C<#

,DAE@A#

,;<=7>?5953>#

,FGH57I95J<#

,:5959=53495J<#

,;1:59#

,K57=5LF4>71>#

!"#$%&'()'*+,-.%/'(0'.123%&'M-NO#*'P#Q53#*'P#R3=#"*S'

Difference in updates = different degrees of engagement?

37

#  of  Updates

Source:  www.twiYer.com,  July  13th,Dec  31st  2009,  October  18th;  whdotpharma  analysis

Avrg  updates:  456

Page 38: Digipharm workshop2011

!"

#!!"

$!!!"

$#!!"

%!!!"

%#!!"

&!!!"

!" %!!" '!!" (!!" )!!" $!!!" $%!!" $'!!"

!"##"$%&'()*+(,"##"$-.*(/0(123.435"6(7-5(89:;5<(=8(

Avrg  following:  793

Avrg  Updates:  456

#  of  Following

#  of  UpdatesAvrg  Bubble  size  =  #  of  followers

Source:  www.twiYer.com,  July  13th  and  Dec  31st  2009;  whdotpharma  analysis

Roche moves into “engaged“ quadrant; AZ and Vertex move closer

@Roche_com

Following  vs.  followers  by  pharmaco:  Oct  10 EngagedListen

TalkThink

Page 39: Digipharm workshop2011
Page 40: Digipharm workshop2011

Example: measuring resultsPublication of Roche guidelines

• Over 100,000 people were reached with the twitter news about the publication of the guidelines

• People commenting on the matter included marketers, journalists, bloggers, doctors and patient advocates

Number of clicks on link + Statistics on inbound traffic on website

Number of re-Tweets or reactions

Stories, comments, relationships created

Page 41: Digipharm workshop2011
Page 42: Digipharm workshop2011